Ryan Preblick, Chief Financial Officer at Indivior Pharmaceuticals, sold INDV on Jun 8, 2026
Data as of Oct 16
▼ SELL$1.4M36,000 shares at $37.70Ryan Preblick Chief Financial OfficerINDV Indivior Pharmaceuticals, Inc.
- Traded
- Jun 8, 2026
- Disclosed
- Jun 10, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
INDV since disclosure
−14.8%
after the sale
Similar stocks (XLV) since disclosure
+15.6%
XLV — its sector index fund
Change in closing price from Jun 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.